This would not be a characteristic pattern of btms in early months of forteo treatment, although one can only tell for sure when there is a baseline for comparison. When this happens, it's important to rule out underlying pathologies contributing to bone turnover derangements. Getting the secondary cause of bone loss under control is key to ensure the success of an anabolic treatment.